tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

RNAZ Stock Latest News

Transcode announces SRC approved third cohort in TTX-MC138 clinical trial
The FlyTranscode announces SRC approved third cohort in TTX-MC138 clinical trial
4d ago
RNAZ
Transcode Therapeutics Inc trading halted, news pending
PremiumThe Fly
Transcode Therapeutics Inc trading halted, news pending
19d ago
RNAZ
TransCode Therapeutics Raises $8M in Private Placement
PremiumCompany Announcements
TransCode Therapeutics Raises $8M in Private Placement
20d ago
8K
RNAZ
TransCode Therapeutics Announces Reverse Stock Split
PremiumCompany Announcements
TransCode Therapeutics Announces Reverse Stock Split
23d ago
8K
RNAZ
Transcode Therapeutics issues 21.2M shares at 37.7c in private placement
PremiumThe Fly
Transcode Therapeutics issues 21.2M shares at 37.7c in private placement
25d ago
RNAZ
Transcode Therapeutics announces 1-for-33 reverse stock split
PremiumThe FlyTranscode Therapeutics announces 1-for-33 reverse stock split
27d ago
RNAZ
Transcode Therapeutics Reports Increased Losses Amid Funding Challenges
Premium
Company Announcements
Transcode Therapeutics Reports Increased Losses Amid Funding Challenges
1M ago
RNAZ
Transcode Therapeutics sends open letter to shareholders
Premium
The Fly
Transcode Therapeutics sends open letter to shareholders
1M ago
RNAZ
Transcode Therapeutics, Inc. (RNAZ) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Transcode Therapeutics, Inc. (RNAZ) Q3 Earnings Cheat Sheet
1M ago
RNAZ
Transcode Therapeutics announces Nasdaq extension to regain compliance
PremiumThe Fly
Transcode Therapeutics announces Nasdaq extension to regain compliance
2M ago
RNAZ
Transcode announces SRC approval of second cohort in Phase 1 TTX-MC138 trial
PremiumThe Fly
Transcode announces SRC approval of second cohort in Phase 1 TTX-MC138 trial
2M ago
RNAZ
Transcode completes initial dosing of first cohort in trial with TTX-MC138
PremiumThe Fly
Transcode completes initial dosing of first cohort in trial with TTX-MC138
2M ago
RNAZ
Transcode announces first patients treated in Phase 1 trial of TTX-MC138
PremiumThe FlyTranscode announces first patients treated in Phase 1 trial of TTX-MC138
3M ago
RNAZ
Transcode Therapeutics announces publication of study on TTX-MC138
Premium
The Fly
Transcode Therapeutics announces publication of study on TTX-MC138
3M ago
RNAZ
Transcode Therapeutics awarded $2M NIH grant to support TTX-MC138
Premium
The Fly
Transcode Therapeutics awarded $2M NIH grant to support TTX-MC138
4M ago
RNAZ
Transcode Therapeutics announces Phase 1 trial initiation
PremiumThe Fly
Transcode Therapeutics announces Phase 1 trial initiation
4M ago
RNAZ
Transcode Therapeutics 10M share Spot Secondary priced at 30c
PremiumThe Fly
Transcode Therapeutics 10M share Spot Secondary priced at 30c
5M ago
RNAZ
Transcode Therapeutics announces common stock offering, no amount given
PremiumThe Fly
Transcode Therapeutics announces common stock offering, no amount given
5M ago
RNAZ
Transcode Therapeutics regains compliance with Nasdaq listing requirements
PremiumThe Fly
Transcode Therapeutics regains compliance with Nasdaq listing requirements
7M ago
RNAZ
Transcode Therapeutics reports data from FIH study of TTX-MC138
PremiumThe FlyTranscode Therapeutics reports data from FIH study of TTX-MC138
7M ago
RNAZ
Transcode Therapeutics board issues letter to shareholders
Premium
The Fly
Transcode Therapeutics board issues letter to shareholders
7M ago
RNAZ
Transcode announces FDA clearance to initiate Phase 1/2 trial of TTX-MC138
Premium
The Fly
Transcode announces FDA clearance to initiate Phase 1/2 trial of TTX-MC138
8M ago
RNAZ

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >